{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:05:25Z","timestamp":1788577525358,"version":"build-2803163510"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Tau positron emission tomography (PET) imaging can reveal the pathophysiology and neurodegeneration that occurs in Alzheimer\u2019s disease (AD)\n                      <jats:italic>in vivo<\/jats:italic>\n                      . The standardized uptake value ratio (SUVR) is widely used for semi-quantification of tau deposition but is susceptible to disturbance from the reference region and the partial volume effect (PVE). To overcome this problem, we applied the parametric estimation of reference signal intensity (PERSI) method\u2014which was previously evaluated for flortaucipir imaging\u2014to two tau tracers, flortaucipir and [\n                      <jats:sup>18<\/jats:sup>\n                      F]-APN-1607.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Two cohorts underwent tau PET scanning. Flortaucipir PET imaging data for cohort I (65 healthy controls [HCs], 60 patients with mild cognitive impairment [MCI], and 12 AD patients) were from the AD Neuroimaging Initiative database. [\n                      <jats:sup>18<\/jats:sup>\n                      F]-APN-1607 ([\n                      <jats:sup>18<\/jats:sup>\n                      F]-PM-PBB3) PET imaging data were for Cohort II, which included 21 patients with a clinical diagnosis of amyloid PET-positive AD and 15 HCs recruited at Huashan Hospital. We used white matter (WM) postprocessed by PERSI (PERSI-WM) as the reference region and compared this with the traditional semi-quantification method that uses the whole cerebellum as the reference. SUVRs were calculated for regions of interest including the frontal, parietal, temporal, and occipital lobes; anterior and posterior cingulate; precuneus; and Braak I\/II (entorhinal cortex and hippocampus). Receiver operating characteristic (ROC) curve analysis and effect sizes were used to compare the two methods in terms of ability to discriminate between different clinical groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In both cohorts, regional SUVR determined using the PERSI-WM method was superior to using the cerebellum as reference region for measuring tau retention in AD patients (e.g., SUVR of the temporal lobe: flortaucipir, 1.08 \u00b1 0.17 and [\n                      <jats:sup>18<\/jats:sup>\n                      F]-APN-1607, 1.57 \u00b1 0.34); and estimates of the effect size and areas under the ROC curve (AUC) indicated that it also increased between-group differences (e.g., AUC of the temporal lobe for HC vs AD: flortaucipir, 0.893 and [\n                      <jats:sup>18<\/jats:sup>\n                      F]-APN-1607: 0.949).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The PERSI-WM method significantly improves diagnostic discrimination compared to conventional approach of using the cerebellum as a reference region and can mitigate the PVE; it can thus enhance the efficacy of semi-quantification of multiple tau tracers in PET scanning, making it suitable for large-scale clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2021.598234","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T01:39:05Z","timestamp":1624239545000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [18F]-APN-1607 Study"],"prefix":"10.3389","volume":"15","author":[{"given":"Huiwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuantao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2967\/jnumed.117.200691","article-title":"Test-Retest reproducibility for the tau PET imaging agent flortaucipir F 18.","volume":"59","author":"Devous","year":"2018","journal-title":"J. Nucl. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0166-2236(91)90105-4","article-title":"Molecular characterization of microtubule-associated proteins tau and MAP2.","volume":"14","author":"Goedert","year":"1991","journal-title":"Trends Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.neurobiolaging.2017.08.008","article-title":"Tau positron emission tomography using [(18)F]THK5351 and cerebral glucose hypometabolism in Alzheimer\u2019s disease.","volume":"59","author":"Kang","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1136\/jnnp-2018-317970","article-title":"Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer\u2019s disease.","volume":"89","author":"Kitamura","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2967\/jnumed.114.148981","article-title":"Measurement of longitudinal beta-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.","volume":"56","author":"Landau","year":"2015","journal-title":"J. Nucl. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge.","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2967\/jnumed.118.208215","article-title":"Brain imaging of Alzheimer dementia patients and elderly controls with (18)F-MK-6240, a PET tracer targeting neurofibrillary tangles.","volume":"60","author":"Lohith","year":"2019","journal-title":"J. Nucl. Med."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00604","article-title":"Associations of [(18)F]-APN-1607 Tau PET binding in the brain of Alzheimer\u2019s disease patients with cognition and glucose metabolism.","volume":"14","author":"Lu","year":"2020","journal-title":"Front. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","article-title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer\u2019s disease.","volume":"157","author":"Maass","year":"2017","journal-title":"Neuroimage"},{"key":"B11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.","volume":"78","author":"Marquie","year":"2015","journal-title":"Ann. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20140119","article-title":"Partial-volume effect correction in positron emission tomography brain scan image using super-resolution image reconstruction.","volume":"88","author":"Meechai","year":"2015","journal-title":"Br. J. Radiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2967\/jnumed.119.236224","article-title":"Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer disease and healthy controls: a first-in-humans study.","volume":"61","author":"Mueller","year":"2020","journal-title":"J. Nucl. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40336-018-0290-y","article-title":"The development and validation of tau PET tracers: current status and future directions.","volume":"6","author":"Okamura","year":"2018","journal-title":"Clin. Transl. Imaging"},{"key":"B16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3233\/BEN-2009-0232","article-title":"Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo.","volume":"21","author":"Rabinovici","year":"2009","journal-title":"Behav. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain.","volume":"89","author":"Scholl","year":"2016","journal-title":"Neuron"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2967\/jnumed.115.170027","article-title":"Kinetics of the Tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment, and Alzheimer disease.","volume":"57","author":"Shcherbinin","year":"2016","journal-title":"J. Nucl. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.dadm.2016.12.009","article-title":"Association between Abeta and tau accumulations and their influence on clinical features in aging and Alzheimer\u2019s disease spectrum brains: a [(11)C]PBB3-PET study.","volume":"6","author":"Shimada","year":"2017","journal-title":"Alzheimers Dement. (Amst.)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.dadm.2017.07.001","article-title":"Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer\u2019s disease: a combined positron emission tomography\/magnetic resonance imaging study.","volume":"9","author":"Sone","year":"2017","journal-title":"Alzheimers Dement. (Amst.)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2967\/jnumed.117.200006","article-title":"Flortaucipir F 18 quantitation using parametric estimation of reference signal intensity.","volume":"59","author":"Southekal","year":"2018","journal-title":"J. Nucl. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"B23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrneurol.2018.9","article-title":"Imaging tau and amyloid-beta proteinopathies in Alzheimer disease and other conditions.","volume":"14","author":"Villemagne","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","article-title":"Tau imaging: early progress and future directions.","volume":"14","author":"Villemagne","year":"2015","journal-title":"Lancet Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.2967\/jnumed.118.209916","article-title":"Characterization of 3 novel tau radiopharmaceuticals, (11)C-RO-963, (11)C-RO-643, and (18)F-RO-948, in healthy controls and in Alzheimer subjects.","volume":"59","author":"Wong","year":"2018","journal-title":"J. Nucl. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.neuroimage.2016.09.031","article-title":"Data-driven identification of intensity normalization region based on longitudinal coherency of (18)F-FDG metabolism in the healthy brain.","volume":"146","author":"Zhang","year":"2017","journal-title":"Neuroimage"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.598234\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T01:39:09Z","timestamp":1624239549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.598234\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":26,"alternative-id":["10.3389\/fnins.2021.598234"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2021.598234","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,21]]},"article-number":"598234"}}